Search Within

Sean McCarthy Devlin

Formats
  1. Meeting Abstract (375)
  2. Journal Article (219)
  3. Research Letter (16)
  4. Correspondence (5)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Biostatistics Service (617)
  2. Epidemiology and Biostatistics (617)
  3. Department of Medicine (588)
  4. Hematologic Malignancies, Division of (587)
  5. Center for Hematologic Malignancies (585)
  6. Bone Marrow Transplant (470)

More Groups

People
  1. Sergio Giralt (380)
  2. Miguel-Angel Perales (303)
  3. Gunjan Shah (187)
  4. Molly Maloy (162)
  5. Parastoo Dahi (161)
  6. Michael Scordo (152)

More People

Years
  1. 2025 (19)
  2. 2024 (35)
  3. 2023 (52)
  4. 2022 (42)
  5. 2021 (36)
  6. 2020 (56)

More Years

Publications
  1. Blood (204)
  2. Biology of Blood and Marrow Transplantation (133)
  3. Bone Marrow Transplantation (51)
  4. Blood Advances (28)
  5. Transplantation and Cellular Therapy (25)
  6. Journal of Clinical Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (232)
  2. Elsevier Inc. (176)
  3. Nature Publishing Group (74)
  4. American Society of Clinical Oncology (16)
  5. Taylor & Francis Group (16)
  6. American Association for Cancer Research (12)

More Publishers

Results (617)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Myeloablative conditioning and CD34+ selection results in higher chronic-GVHD free/relapse free-survival compared to reduced-intensity conditioning and unmodified graft in patients with AML and MDS > 50 years receiving HLA-matched allogeneic HCT
    Meeting Abstract

    Barba, P.; Martino, R.; Zhou, Q.; Cho, C.; Castro-Malaspina, H.; Devlin, S.; Esquirol, A.; Giralt, S.; Jakubowski, A.; Lopez-Corral, L.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Devlin, S.; Maloy, M.; Kosuri, S.; Herrera, D. A.; Nieves, J.; Avecilla, S. T.; Meagher, R. C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Acute toxicities in patients receiving ex-vivo CD34+ selected allogeneic stem cell transplantation for hematologic malignancies
    Meeting Abstract

    Herrera, D.; Perales, M. A.; Shah, G.; Scordo, M.; Devlin, S.; Maloy, M.; Nieves, J.; Avecilla, S.; Meagher, R.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Toxicities in older adult patients undergoing CD34+ selected allogeneic hematopoietic stem cell transplantation (allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M.; Nieves, J. L.; Devlin, S.; Avecilla, S. T.; Meagher, R.; Shaffer, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Long-term prognosis of one-year survivors of CD34-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis
    Meeting Abstract

    Cho, C.; Hsu, M.; Avecilla, S.; Barba, P.; Barker, J.; Castro-Malaspina, H.; Devlin, S.; Giralt, S.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Avila, A. M.; Barba, P.; Cho, C.; Devlin, S.; Ceberio, I.; Ponce, D.; Maloy, M.; Perales, M. A.
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
    Journal Article

    Lendvai, N.; Yee, A. J.; Tsakos, I.; Alexander, A.; Devlin, S. M.; Hassoun, H.; Korde, N.; Lesokhin, A. M.; Landau, H.; Mailankody, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: Efficacy and cost analysis study
    Journal Article

    Afifi, S.; Adel, N. G.; Devlin, S.; Duck, E.; Vanak, J.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Korde, N.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • T-cell exhaustion in multiple myeloma relapse after autotransplant: Optimal timing of immunotherapy
    Journal Article

    Chung, D. J.; Pronschinske, K. B.; Shyer, J. A.; Sharma, S.; Leung, S.; Curran, S. A.; Lesokhin, A. M.; Devlin, S. M.; Giralt, S. A.; Young, J. W.
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save